Tiracizine
Names | |
---|---|
IUPAC name
ethyl N-[11-[2-(dimethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-9-yl]carbamate
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
KEGG | |
PubChem CID
|
|
| |
| |
Properties | |
C21H25N3O3 | |
Molar mass | 367.4415 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
WikiDoc Resources for Tiracizine |
Articles |
---|
Most recent articles on Tiracizine |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tiracizine at Clinical Trials.gov Clinical Trials on Tiracizine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tiracizine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tiracizine Discussion groups on Tiracizine Patient Handouts on Tiracizine Directions to Hospitals Treating Tiracizine Risk calculators and risk factors for Tiracizine
|
Healthcare Provider Resources |
Causes & Risk Factors for Tiracizine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tiracizine is an antiarrhythmic agent.